CORRESP

BMO Capital Markets Corp.

3 Times Square

New York, New York 10036

Wells Fargo Securities, LLC

375 Park Avenue

New York, New York 10152

UBS Securities LLC

1285 Avenue of the Americas

New York, New York 10019

October 28, 2019

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:

Ms. Sonia Bednarowski
Mr. Dietrich King
Ms. Sasha Parikh
Mr. Jim Rosenberg

 

Re:

RAPT Therapeutics, Inc.
Registration Statement on Form S-1, as amended (File No. 333-232572)
Request for Acceleration of Effective Date

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of RAPT Therapeutics, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Time, on October 30, 2019, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have carried out the following distribution of the Company’s preliminary prospectus dated October 28, 2019:

 

  (i)

Dates of distribution: October 28, 2019

 

  (ii)

Number of prospective underwriters to which the preliminary prospectus was furnished: 3

 

  (iii)

Number of preliminary prospectuses furnished to investors: approximately 315

 

  (iv)

Number of preliminary prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: approximately 135

We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature page follows]


Very truly yours,

BMO CAPITAL MARKETS CORP.

WELLS FARGO SECURITIES, LLC

UBS SECURITIES LLC

 

As representatives of the several underwriters listed in Schedule A to the Underwriting Agreement

 

BMO CAPITAL MARKETS CORP.

By:

 

/s/ Annette Grimaldi

 

Name:

 

Annette Grimaldi

 

Title:

 

Managing Director

WELLS FARGO SECURITIES, LLC

By:

 

/s/ Geoff Goodman

 

Name:

 

Geoff Goodman

 

Title:

 

Managing Director

UBS SECURITIES LLC

By:

 

/s/ Robin Tang

 

Name:

 

Robin Tang

 

Title:

 

Director

By:

 

/s/ James Stahlke

 

Name:

 

James Stahlke

 

Title:

 

Associate Director

[Signature Page to Underwriters’ Acceleration Request]